• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种经过计算设计的水溶性 G 蛋白偶联受体变体:人 μ 阿片受体。

A computationally designed water-soluble variant of a G-protein-coupled receptor: the human mu opioid receptor.

机构信息

Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.

出版信息

PLoS One. 2013 Jun 14;8(6):e66009. doi: 10.1371/journal.pone.0066009. Print 2013.

DOI:10.1371/journal.pone.0066009
PMID:23799068
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3682944/
Abstract

G-protein-coupled receptors (GPCRs) play essential roles in various physiological processes, and are widely targeted by pharmaceutical drugs. Despite their importance, studying GPCRs has been problematic due to difficulties in isolating large quantities of these membrane proteins in forms that retain their ligand binding capabilities. Creating water-soluble variants of GPCRs by mutating the exterior, transmembrane residues provides a potential method to overcome these difficulties. Here we present the first study involving the computational design, expression and characterization of water-soluble variant of a human GPCR, the human mu opioid receptor (MUR), which is involved in pain and addiction. An atomistic structure of the transmembrane domain was built using comparative (homology) modeling and known GPCR structures. This structure was highly similar to the subsequently determined structure of the murine receptor and was used to computationally design 53 mutations of exterior residues in the transmembrane region, yielding a variant intended to be soluble in aqueous media. The designed variant expressed in high yield in Escherichia coli and was water soluble. The variant shared structural and functionally related features with the native human MUR, including helical secondary structure and comparable affinity for the antagonist naltrexone (Kd = 65 nM). The roles of cholesterol and disulfide bonds on the stability of the receptor variant were also investigated. This study exemplifies the potential of the computational approach to produce water-soluble variants of GPCRs amenable for structural and functionally related characterization in aqueous solution.

摘要

G 蛋白偶联受体(GPCRs)在各种生理过程中发挥着重要作用,是药物广泛靶向的对象。尽管它们很重要,但由于难以以保留配体结合能力的形式分离大量这些膜蛋白,因此研究 GPCRs 一直存在问题。通过突变外部分子、跨膜残基来创建 GPCR 的水溶性变体提供了一种潜在的克服这些困难的方法。在这里,我们首次报道了涉及计算设计、表达和鉴定水溶性人 GPCR(人类 μ 阿片受体,MUR)变体的研究,MUR 参与疼痛和成瘾。使用比较(同源)建模和已知 GPCR 结构构建了跨膜域的原子结构。该结构与随后确定的鼠类受体结构高度相似,并用于计算设计跨膜区域的 53 个外部残基突变,产生一种预期可溶于水相的变体。该设计变体在大肠杆菌中高表达且水溶性好。该变体与天然人 MUR 具有结构和功能相关的特征,包括螺旋二级结构和类似的拮抗剂纳曲酮亲和力(Kd=65 nM)。还研究了胆固醇和二硫键对受体变体稳定性的作用。本研究例证了计算方法在产生可用于水相结构和功能相关鉴定的水溶性 GPCR 变体方面的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fd/3682944/806394a31ba5/pone.0066009.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fd/3682944/bd14ff321fed/pone.0066009.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fd/3682944/2b7a7dedadb9/pone.0066009.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fd/3682944/5cf6527277b8/pone.0066009.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fd/3682944/f347f56af822/pone.0066009.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fd/3682944/e01b69e249d9/pone.0066009.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fd/3682944/806394a31ba5/pone.0066009.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fd/3682944/bd14ff321fed/pone.0066009.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fd/3682944/2b7a7dedadb9/pone.0066009.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fd/3682944/5cf6527277b8/pone.0066009.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fd/3682944/f347f56af822/pone.0066009.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fd/3682944/e01b69e249d9/pone.0066009.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8fd/3682944/806394a31ba5/pone.0066009.g006.jpg

相似文献

1
A computationally designed water-soluble variant of a G-protein-coupled receptor: the human mu opioid receptor.一种经过计算设计的水溶性 G 蛋白偶联受体变体:人 μ 阿片受体。
PLoS One. 2013 Jun 14;8(6):e66009. doi: 10.1371/journal.pone.0066009. Print 2013.
2
Characterization of a computationally designed water-soluble human μ-opioid receptor variant using available structural information.利用现有结构信息对通过计算设计的水溶性人μ-阿片受体变体进行表征。
Anesthesiology. 2014 Oct;121(4):866-75. doi: 10.1097/ALN.0000000000000308.
3
Novel variants of engineered water soluble mu opioid receptors with extensive mutations and removal of cysteines.具有广泛突变和半胱氨酸缺失的工程水溶性 μ 阿片受体的新型变体。
Proteins. 2021 Oct;89(10):1386-1393. doi: 10.1002/prot.26160. Epub 2021 Jun 29.
4
Characterization of an engineered water-soluble variant of the full-length human mu opioid receptor.全长人 μ 阿片受体水溶性工程变体的表征。
J Biomol Struct Dyn. 2020 Sep;38(14):4364-4370. doi: 10.1080/07391102.2019.1677502. Epub 2019 Oct 17.
5
Homology modeling and molecular dynamics simulations of the mu opioid receptor in a membrane-aqueous system.μ阿片受体在膜-水体系中的同源建模与分子动力学模拟
Chembiochem. 2005 May;6(5):853-9. doi: 10.1002/cbic.200400207.
6
Mutation of human mu opioid receptor extracellular "disulfide cysteine" residues alters ligand binding but does not prevent receptor targeting to the cell plasma membrane.人类μ阿片受体细胞外“二硫键半胱氨酸”残基的突变会改变配体结合,但不会阻止受体靶向细胞膜。
Brain Res Mol Brain Res. 1999 Oct 1;72(2):195-204. doi: 10.1016/s0169-328x(99)00241-7.
7
Comparative modeling and molecular dynamics studies of the delta, kappa and mu opioid receptors.δ、κ和μ阿片受体的比较建模与分子动力学研究
Protein Eng. 1997 Sep;10(9):1019-38. doi: 10.1093/protein/10.9.1019.
8
Comparison of the amino acid residues in the sixth transmembrane domains accessible in the binding-site crevices of mu, delta, and kappa opioid receptors.μ、δ和κ阿片受体结合位点裂隙中可及的第六个跨膜结构域氨基酸残基的比较。
Biochemistry. 2001 Jul 10;40(27):8018-29. doi: 10.1021/bi002490d.
9
3D modeling, ligand binding and activation studies of the cloned mouse delta, mu; and kappa opioid receptors.克隆的小鼠δ、μ和κ阿片受体的3D建模、配体结合及激活研究。
Protein Eng. 1999 Nov;12(11):927-42. doi: 10.1093/protein/12.11.927.
10
Optimized Proteomic Mass Spectrometry Characterization of Recombinant Human μ-Opioid Receptor Functionally Expressed in Pichia pastoris Cell Lines.在毕赤酵母细胞系中功能表达的重组人μ-阿片受体的优化蛋白质组质谱表征
J Proteome Res. 2015 Aug 7;14(8):3162-73. doi: 10.1021/acs.jproteome.5b00104. Epub 2015 Jul 7.

引用本文的文献

1
Solubilization of Membrane Proteins using designed protein WRAPS.使用设计的蛋白质WRAPS溶解膜蛋白。
bioRxiv. 2025 Feb 5:2025.02.04.636539. doi: 10.1101/2025.02.04.636539.
2
Computational design of soluble and functional membrane protein analogues.可溶性和功能型膜蛋白类似物的计算设计。
Nature. 2024 Jul;631(8020):449-458. doi: 10.1038/s41586-024-07601-y. Epub 2024 Jun 19.
3
Design of a water-soluble transmembrane receptor kinase with intact molecular function by QTY code.通过 QTY 编码设计具有完整分子功能的水溶性跨膜受体激酶。

本文引用的文献

1
Human μ Opioid Receptor Models with Evaluation of the Accuracy Using the Crystal Structure of the Murine μ Opioid Receptor.利用小鼠μ阿片受体晶体结构评估准确性的人类μ阿片受体模型
J Anesth Clin Res. 2012 Jul 2;3(6):218. doi: 10.4172/2155-6148.1000218.
2
Structural basis for allosteric regulation of GPCRs by sodium ions.钠离子对 G 蛋白偶联受体变构调节的结构基础。
Science. 2012 Jul 13;337(6091):232-6. doi: 10.1126/science.1219218.
3
Structure of the δ-opioid receptor bound to naltrindole.δ-阿片受体与纳曲吲哚结合的结构。
Nat Commun. 2024 Jun 10;15(1):4293. doi: 10.1038/s41467-024-48513-9.
4
Exploring GPCR conformational dynamics using single-molecule fluorescence.利用单分子荧光技术探索 G 蛋白偶联受体构象动力学。
Methods. 2024 Jun;226:35-48. doi: 10.1016/j.ymeth.2024.03.011. Epub 2024 Apr 10.
5
Tyrosine 7.43 is important for mu-opioid receptor downstream signaling pathways activated by fentanyl.酪氨酸7.43对于芬太尼激活的μ-阿片受体下游信号通路很重要。
Front Pharmacol. 2022 Sep 2;13:919325. doi: 10.3389/fphar.2022.919325. eCollection 2022.
6
Protein Design: From the Aspect of Water Solubility and Stability.蛋白质设计:从水溶性和稳定性方面考虑。
Chem Rev. 2022 Sep 28;122(18):14085-14179. doi: 10.1021/acs.chemrev.1c00757. Epub 2022 Aug 3.
7
Membrane Protein Engineering with Rosetta.利用 Rosetta 进行膜蛋白工程。
Methods Mol Biol. 2021;2315:43-57. doi: 10.1007/978-1-0716-1468-6_3.
8
Novel variants of engineered water soluble mu opioid receptors with extensive mutations and removal of cysteines.具有广泛突变和半胱氨酸缺失的工程水溶性 μ 阿片受体的新型变体。
Proteins. 2021 Oct;89(10):1386-1393. doi: 10.1002/prot.26160. Epub 2021 Jun 29.
9
The G protein coupled receptor CXCR4 designed by the QTY code becomes more hydrophilic and retains cell signaling activity.由 QTY 编码设计的 G 蛋白偶联受体 CXCR4 变得更亲水,并保留细胞信号转导活性。
Sci Rep. 2020 Dec 7;10(1):21371. doi: 10.1038/s41598-020-77659-x.
10
Molecular Interaction Between Butorphanol and κ-Opioid Receptor.布托啡诺与 κ 型阿片受体的分子相互作用。
Anesth Analg. 2020 Sep;131(3):935-942. doi: 10.1213/ANE.0000000000005017.
Nature. 2012 May 16;485(7398):400-4. doi: 10.1038/nature11111.
4
Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic.阿片肽孤儿受体与肽模拟物复合物的结构。
Nature. 2012 May 16;485(7398):395-9. doi: 10.1038/nature11085.
5
The role of cholesterol on the activity and stability of neurotensin receptor 1.胆固醇对神经降压素受体1活性和稳定性的作用。
Biochim Biophys Acta. 2012 Sep;1818(9):2228-33. doi: 10.1016/j.bbamem.2012.04.010. Epub 2012 Apr 20.
6
Beyond the detergent effect: a binding site for sodium dodecyl sulfate (SDS) in mammalian apoferritin.除去污剂作用外:哺乳动物脱铁铁蛋白中十二烷基硫酸钠(SDS)的结合位点。
Acta Crystallogr D Biol Crystallogr. 2012 May;68(Pt 5):497-504. doi: 10.1107/S0907444912002740. Epub 2012 Apr 17.
7
Structure of the human κ-opioid receptor in complex with JDTic.人κ-阿片受体与 JDTic 复合物的结构。
Nature. 2012 Mar 21;485(7398):327-32. doi: 10.1038/nature10939.
8
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist.μ-阿片受体与吗啡喃拮抗剂结合的晶体结构
Nature. 2012 Mar 21;485(7398):321-6. doi: 10.1038/nature10954.
9
Computational design of membrane proteins.膜蛋白的计算设计。
Structure. 2012 Jan 11;20(1):5-14. doi: 10.1016/j.str.2011.12.003.
10
NMR structure and dynamics of a designed water-soluble transmembrane domain of nicotinic acetylcholine receptor.烟碱型乙酰胆碱受体设计的水溶性跨膜结构域的核磁共振结构与动力学
Biochim Biophys Acta. 2012 Mar;1818(3):617-26. doi: 10.1016/j.bbamem.2011.11.021. Epub 2011 Dec 3.